We previously showed that NF-κB is aberrantly activated and modulates the expression of gene clusters that include oncogenes that promote survival, tumorigenesis and therapeutic resistance of advanced murine and human squamous cell carcinomas [6-16]. This evidence concerns the gene NFKB1 and squamous cell carcinoma.